Vigabatrin Powder, For Solution
Product Images NDC 70710-1494

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70710-1494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 01)

Chemical structure of vigabatrin showing the molecular arrangement of atoms including an amino group, carboxylic acid group, and a vinyl substituent.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 02)

A line graph showing percentage reduction in seizure frequency plotted against the percentage of patients. The graph compares results for placebo and three vigabatrin (VGB) dosages: 1 g/day, 3 g/day, and 6 g/day. The y-axis ranges from worsening to improvement with no change at zero percent. The x-axis represents the percentage of patients. Four distinct lines represent the different treatment groups, illustrating the varying degrees of seizure frequency reduction.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 03)

A cumulative frequency plot comparing the percentage reduction in seizure frequency between placebo and 3g/day vigabatrin (VGB) treatments. The horizontal axis represents the percentage of patients, while the vertical axis shows the percent change in seizure frequency, with improvement and worsening directions indicated.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 04)

Vigabatrin for Oral Solution, USP 500 mg strength powder for solution in a glass, produced by Zydus Pharmaceuticals (USA) Inc. The image shows the powder reconstituted in water with a spoon, syringes, and scissors nearby, implying preparation for oral administration.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 05)

An instructional illustration showing details of an oral syringe. It labels the tip, dosage indicators, barrel, bottom of the white plunger, and the plunger itself, highlighting the components relevant for measuring and administering oral medication.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 06)

Packaging label of vigabatrin oral solution USP, 500 mg/10 mL, from Zydus Pharmaceuticals (USA) Inc. The image shows a hand pouring the liquid medication from a container into a clear glass, illustrating the powder for solution oral dosage form.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 07)

Figure showing two clear glasses, one partially filled with water and the other empty, likely illustrating a preparation or dilution step for an oral solution.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 08)

Illustration showing a pair of gloved hands holding a container inside a glass of water, suggesting preparation or dissolution of a medication by mixing powder with water. Caption below reads 'Figure C.'*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 09)

An instructional illustration labeled 'Figure D' showing a hand holding a syringe filled with liquid medication, likely demonstrating measurement or administration technique for oral solution.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 10)

An illustration showing a hand holding an oral dosing syringe with a black marking aligned at the 10 mL line, labeled with an arrow and text stating "10 mL line." The image demonstrates how to measure 10 mL of liquid dose.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 11)

An illustration labeled Figure F showing a hand holding an oral dosing syringe, positioned above an empty glass. The syringe appears to be dispensing liquid into the glass, demonstrating proper administration or measurement technique for oral liquid medication.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 12)

Illustration showing a hand holding a spoon over an empty glass container, likely demonstrating a step in preparing or administering an oral powder for solution.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 13)

An instructional illustration labeled as Figure H showing a hand holding and using a syringe inside a clear glass container, likely demonstrating a step for measuring or transferring liquid, possibly related to preparation or administration of the oral powder for solution medication.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 14)

Black and white instructional illustration showing a hand holding a syringe filled with a liquid, marked with measurement graduations. The image appears to demonstrate preparation or measurement of an oral solution, relevant to the dosage form of vigabatrin powder for solution.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 15)

An instructional illustration showing a young child receiving an oral dose of medication using a syringe without a needle, administered by an adult hand into the child's mouth.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 16)

Label for Vigabatrin for Oral Solution, USP 500 mg powder for oral solution, presented as a single packet. The label includes instructions to mix each packet with 10 mL of water before use. It is manufactured by Zydus Lifesciences Ltd. in India and distributed by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

Image (657ca636 2636 4260 B826 558d39109172 17)

Label for Vigabatrin for Oral Solution USP 500 mg powder for solution in 50 packets, manufactured by Zydus Pharmaceuticals USA. The label includes directions to mix each packet with 10 mL water and storage instructions. It features the NDC 70710-1494-8 and identifies the labeler as Zydus Lifesciences Ltd., India, with distribution by Zydus Pharmaceuticals USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.